ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Heron Therapeautics Inc

Heron Therapeautics Inc (HRTX)

1,58
0,05
(3,27%)
Geschlossen 22 Dezember 10:00PM
1,54
-0,04
(-2,53%)
Nach Börsenschluss: 1:51AM

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Wichtige Statistiken und Details

Current Price
1,54
Gebot
1,35
Fragen
2,35
Volumen
2.571.113
1,46 Tagesbereich 1,62
1,04 52-Wochen-Bereich 3,93
Marktkapitalisierung
Handelsende
1,53
Handelsbeginn
1,48
Letzte Trade
1
@
1.47
Letzter Handelszeitpunkt
Finanzvolumen
US$ 3.985.070
VWAP
1,5499
Durchschnittliches Volumen (3 Mio.)
3.182.717
Ausgegebene Aktien
152.094.912
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,16
Gewinn pro Aktie (EPS)
-0,73
Erlöse
127,04M
Nettogewinn
-110,56M

Über Heron Therapeautics Inc

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011. Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Heron Therapeautics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker HRTX. The last closing price for Heron Therapeautics was US$1,53. Over the last year, Heron Therapeautics shares have traded in a share price range of US$ 1,04 to US$ 3,93.

Heron Therapeautics currently has 152.094.912 shares in issue. The market capitalisation of Heron Therapeautics is US$232,71 million. Heron Therapeautics has a price to earnings ratio (PE ratio) of -2.16.

HRTX Neueste Nachrichten

U.S. District Court Upholds Validity of CINVANTI® Patents

U.S. District Court Upholds Validity of CINVANTI® Patents PR Newswire SAN DIEGO, Dec. 3, 2024 — Court Rules in Favor of Heron in Patent Lawsuit Against Fresenius Kabi USA, LLC — SAN DIEGO, Dec...

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance

Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance PR Newswire SAN DIEGO, Nov. 12, 2024 Reported positive YTD 2024 Adjusted EBITDA of $1.4...

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors

Heron Therapeutics Announces Appointment of Michael Kaseta to Board of Directors PR Newswire SAN DIEGO, Nov. 4, 2024 SAN DIEGO, Nov. 4, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq:...

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024

Heron Therapeutics to Report Third Quarter 2024 Financial Results On Tuesday, November 12, 2024 PR Newswire SAN DIEGO, Oct. 29, 2024 SAN DIEGO, Oct. 29, 2024 /PRNewswire/ -- Heron Therapeutics...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.09-5.521472392641.631.71.48523440561.60300201CS
40.4642.59259259261.081.991.0660972351.56952637CS
12-0.53-25.60386473432.072.151.0431827171.59487689CS
26-1.85-54.57227138643.393.731.0427310841.98013936CS
52-0.17-9.941520467841.713.931.0426638642.3181398CS
156-7.915-83.7123215239.45510.460.525685472.88242071CS
260-23.71-93.90099009925.2525.750.520610386.00543534CS

HRTX - Frequently Asked Questions (FAQ)

What is the current Heron Therapeautics share price?
The current share price of Heron Therapeautics is US$ 1,54
How many Heron Therapeautics shares are in issue?
Heron Therapeautics has 152.094.912 shares in issue
What is the market cap of Heron Therapeautics?
The market capitalisation of Heron Therapeautics is USD 232,71M
What is the 1 year trading range for Heron Therapeautics share price?
Heron Therapeautics has traded in the range of US$ 1,04 to US$ 3,93 during the past year
What is the PE ratio of Heron Therapeautics?
The price to earnings ratio of Heron Therapeautics is -2,16
What is the cash to sales ratio of Heron Therapeautics?
The cash to sales ratio of Heron Therapeautics is 1,88
What is the reporting currency for Heron Therapeautics?
Heron Therapeautics reports financial results in USD
What is the latest annual turnover for Heron Therapeautics?
The latest annual turnover of Heron Therapeautics is USD 127,04M
What is the latest annual profit for Heron Therapeautics?
The latest annual profit of Heron Therapeautics is USD -110,56M
What is the registered address of Heron Therapeautics?
The registered address for Heron Therapeautics is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Heron Therapeautics website address?
The website address for Heron Therapeautics is www.herontx.com
Which industry sector does Heron Therapeautics operate in?
Heron Therapeautics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
MYSZMy Size Inc
US$ 4,2001
(211,12%)
121,03M
NVNINVNI Group Ltd
US$ 8,26
(209,36%)
78,06M
TPICTPI Composites Inc
US$ 2,45
(100,82%)
34M
ICGIntchains Group Ltd
US$ 8,77
(88,60%)
527,94k
HSDTHelius Medical Technologies Inc
US$ 0,884851
(84,34%)
121,95M
CYNCYNGN Inc
US$ 0,4603
(-71,41%)
27,5M
MTEMMolecular Templates Inc
US$ 0,1502
(-57,09%)
8,63M
PRFXPainReform Ltd
US$ 5,15
(-53,85%)
2,84M
GALTGalectin Therapeutics Inc
US$ 1,03
(-48,50%)
8,58M
BCABBioAtla Inc
US$ 0,6923
(-41,82%)
5,96M
EDBLEdible Garden AG Inc
US$ 0,24
(65,06%)
354,32M
APTOAptose Biosciences Inc
US$ 0,28
(64,51%)
305,1M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,606999
(6,49%)
292,16M
NVDANVIDIA Corporation
US$ 134,70
(3,08%)
287,21M
PLTRPalantir Technologies Inc
US$ 80,55
(8,54%)
277,63M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock